Patent Oppositions in nervous system drugs industry

Explore the competitive field of nervous system drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in nervous system drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the nervous system drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the nervous system drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 8, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Treatment Of Post-Operative Surgical PainIPSEN BIOPHARMSep 17, 2026MERZ PHARMA
Safe And Effective Method Of Treating Psoriasis With Anti-Il23 Specific AntibodyJANSSEN BIOTECHSep 3, 2026NEUEFEIND
Solid Dosage Forms And Dosing Regimens Comprising (2R,3S,4S,5R)-4-[[3-(3,4-Difluoro-2-Methoxy-Phenyl)-4,5-Dimethyl-5-(Trifluoromethyl) Tetrahydrofuran-2-Carbonyl]Amino]Pyridine-2-CarboxamideVERTEX PHARMACEUTICALS INCORPORATEDSep 3, 2026BARDEHLE PAGENBERG
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZERSep 3, 2026GRUNECKER PATENT UND RECHTSANWALTE PARTG MBB
Safe And Effective Method Of Treating Psoriasis With Anti-Il23 Specific AntibodyJANSSEN BIOTECHSep 2, 2026MAIWALD PATENTANWALTS
Solid Dosage Forms And Dosing Regimens Comprising (2R,3S,4S,5R)-4-[[3-(3,4-Difluoro-2-Methoxy-Phenyl)-4,5-Dimethyl-5-(Trifluoromethyl) Tetrahydrofuran-2-Carbonyl]Amino]Pyridine-2-CarboxamideVERTEX PHARMACEUTICALS INCORPORATEDSep 2, 2026DEVA
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZERSep 2, 2026QUIMICA SINTETICA
Safe And Effective Method Of Treating Psoriasis With Anti-Il23 Specific AntibodyJANSSEN BIOTECHSep 1, 2026GEDEON RICHTER PHARMA
Nicotine Particles And CompositionsPHILIP MORRISAug 19, 2026JT INTERNATIONAL S.A.
Nutritional ProductUCL BUSINESSAug 7, 2026MOLNIA

To stay ahead in the competitive nervous system drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the nervous system drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 8, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA21
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS9
Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA9
Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA9
Dec 3, 2025Safe And Effective Method Of Treating Psoriasis With Anti-Il23 Specific AntibodyJANSSEN BIOTECH8
Oct 9, 2024Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICAL8
Jul 15, 2020Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep InhibitorNOVARTIS8
Apr 10, 2019Dosage Form Containing Oxycodone And NaloxoneEURO CELTIQUE7
Jun 30, 2021Method For Treating Primary InsomniaNEURIM PHARMACEUTICALS7
Sep 2, 2015Polymorphic Form Of RotigotineUCB PHARMA7